Implication of CD35, CD21 and CD55 in Exudative Age-related Macular Degeneration
The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2010 by Rudolf Foundation Clinic.
Recruitment status was Active, not recruiting
Recruitment status was Active, not recruiting
Sponsor:
Rudolf Foundation Clinic
Information provided by:
Rudolf Foundation Clinic
ClinicalTrials.gov Identifier:
NCT01174407
First received: November 19, 2008
Last updated: August 2, 2010
Last verified: August 2010
| Tracking Information | |
|---|---|
| First Received Date ICMJE | November 19, 2008 |
| Last Updated Date | August 2, 2010 |
| Start Date ICMJE | September 2008 |
| Estimated Primary Completion Date | December 2009 (final data collection date for primary outcome measure) |
| Current Primary Outcome Measures ICMJE |
determine a possible implication of CD21, CD35 and CD55 in the pathogenesis of age-related macular degeneration [ Time Frame: 1 day ] [ Designated as safety issue: No ] |
| Original Primary Outcome Measures ICMJE | Same as current |
| Change History | Complete list of historical versions of study NCT01174407 on ClinicalTrials.gov Archive Site |
| Current Secondary Outcome Measures ICMJE |
expression rates of on AMD-patients and a healthy control group [ Time Frame: 1 year ] [ Designated as safety issue: No ] |
| Original Secondary Outcome Measures ICMJE | Same as current |
| Current Other Outcome Measures ICMJE | Not Provided |
| Original Other Outcome Measures ICMJE | Not Provided |
| Descriptive Information | |
| Brief Title ICMJE | Implication of CD35, CD21 and CD55 in Exudative Age-related Macular Degeneration |
| Official Title ICMJE | Is CD35, CD21 and CD55 Associated With Exudative Age-related Macular Degeneration |
| Brief Summary | The purpose of this study is to determine a possible implication of CD21, CD35 and CD55 in the pathogenesis of age-related macular degeneration. The aim is to asses a difference in expression rates of these factors on AMD-patients and a healthy control group. |
| Detailed Description | Not Provided |
| Study Type ICMJE | Observational |
| Study Design ICMJE | Observational Model: Case Control Time Perspective: Prospective |
| Target Follow-Up Duration | Not Provided |
| Biospecimen | Not Provided |
| Sampling Method | Non-Probability Sample |
| Study Population | patients with exudative age-related macular degeneration, over 55 |
| Condition ICMJE | Age-Related Macular Degeneration |
| Intervention ICMJE | Other: cd 35, cd21, cd55
Blood drawing/ 10ml/ once- duration of 1 day of full examination of the patient |
| Study Group/Cohort (s) | cd35
Intervention: Other: cd 35, cd21, cd55 |
| Publications * | Haas P, Aggermann T, Nagl M, Steindl-Kuscher K, Krugluger W, Binder S. Implication of CD21, CD35, and CD55 in the pathogenesis of age-related macular degeneration. Am J Ophthalmol. 2011 Sep;152(3):396-399.e1. Epub 2011 Jun 12. |
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|
| Recruitment Information | |
| Recruitment Status ICMJE | Active, not recruiting |
| Estimated Enrollment ICMJE | 120 |
| Estimated Completion Date | August 2010 |
| Estimated Primary Completion Date | December 2009 (final data collection date for primary outcome measure) |
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
| Gender | Both |
| Ages | 55 Years and older |
| Accepts Healthy Volunteers | Yes |
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects |
| Location Countries ICMJE | Austria |
| Administrative Information | |
| NCT Number ICMJE | NCT01174407 |
| Other Study ID Numbers ICMJE | EK08010-VK |
| Has Data Monitoring Committee | No |
| Responsible Party | Prof. Dr. Susanne Binder, Rudolf Foundation Clinic |
| Study Sponsor ICMJE | Rudolf Foundation Clinic |
| Collaborators ICMJE | Not Provided |
| Investigators ICMJE | Not Provided |
| Information Provided By | Rudolf Foundation Clinic |
| Verification Date | August 2010 |
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|